| scholarly article | Q13442814 |
| P50 | author | David Henshall | Q42680688 |
| Eva M Jiménez-Mateos | Q64681858 | ||
| P2093 | author name string | Raymond L Stallings | |
| Isabella Bray | |||
| Roger P Simon | |||
| Takanori Sano | |||
| Ross C McKiernan | |||
| P2860 | cites work | MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2 | Q21245700 |
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo | Q24610134 | ||
| Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation | Q24621879 | ||
| An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP | Q24645518 | ||
| Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps | Q24645826 | ||
| Cerebellar neurodegeneration in the absence of microRNAs | Q24676165 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| The widespread regulation of microRNA biogenesis, function and decay | Q28131796 | ||
| Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor | Q28372013 | ||
| A dicer-independent miRNA biogenesis pathway that requires Ago catalysis | Q28508177 | ||
| MeCP2-dependent repression of an imprinted miR-184 released by depolarization | Q28586909 | ||
| Neuronal activity regulates hippocampal miRNA expression | Q28744351 | ||
| Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects | Q30524857 | ||
| Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival | Q33516231 | ||
| Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration | Q33915341 | ||
| Understanding microRNAs in neurodegeneration | Q33995527 | ||
| MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration | Q34101214 | ||
| Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex | Q34112461 | ||
| Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b | Q34168627 | ||
| Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. | Q34170732 | ||
| Seizure preconditioning and epileptic tolerance: models and mechanisms | Q34617266 | ||
| Ischemic tolerance and endogenous neuroprotection | Q35126696 | ||
| Cell signaling underlying epileptic behavior. | Q35151927 | ||
| miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132 | Q35475193 | ||
| Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation | Q35606143 | ||
| Effect of (S)-3,5-DHPG on microRNA expression in mouse brain | Q35935936 | ||
| Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis | Q35962195 | ||
| Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration | Q36405113 | ||
| Cerebral preconditioning and ischaemic tolerance | Q36484538 | ||
| Microarray profile of seizure damage-refractory hippocampal CA3 in a mouse model of epileptic preconditioning | Q36497101 | ||
| Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis | Q36721626 | ||
| Argonaute proteins: mediators of RNA silencing | Q36845844 | ||
| MicroRNA function in neuronal development, plasticity and disease | Q37056800 | ||
| Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus | Q37352375 | ||
| Alterations of the microRNA network cause neurodegenerative disease. | Q37408476 | ||
| Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance | Q37426724 | ||
| Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies | Q37615626 | ||
| Epigenetic modifications as therapeutic targets | Q37800011 | ||
| Akt signalling in health and disease. | Q37881228 | ||
| Differential DNA methylation patterns define status epilepticus and epileptic tolerance. | Q38498575 | ||
| MicroRNAs induced during ischemic preconditioning | Q39860348 | ||
| Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways | Q39881747 | ||
| Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy | Q39893640 | ||
| A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity | Q41845562 | ||
| MicroRNA-34a upregulation during seizure-induced neuronal death | Q42560262 | ||
| Epileptic tolerance is associated with enduring neuroprotection and uncoupling of the relationship between CA3 damage, neuropeptide Y rearrangement and spontaneous seizures following intra-amygdala kainic acid-induced status epilepticus in mice. | Q42908981 | ||
| Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. | Q44487940 | ||
| Hippocampal transcriptome after status epilepticus in mice rendered seizure damage-tolerant by epileptic preconditioning features suppressed calcium and neuronal excitability pathways. | Q46356689 | ||
| Hippocampal granule cell activity and c-Fos expression during spontaneous seizures in awake, chronically epileptic, pilocarpine-treated rats: implications for hippocampal epileptogenesis | Q46562583 | ||
| Proliferating progenitor cells: a required cellular element for induction of ischemic tolerance in the brain | Q46718848 | ||
| Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states | Q48182556 | ||
| Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. | Q54396512 | ||
| Ischemic tolerance in the brain | Q73089879 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 346-354 | |
| P577 | publication date | 2012-07-05 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death | |
| P478 | volume | 237 |
| Q50533164 | 2R,4R-APDC, a Metabotropic Glutamate Receptor Agonist, Reduced Neuronal Apoptosis by Upregulating MicroRNA-128 in a Rat Model After Seizures. |
| Q38246632 | A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts |
| Q48168497 | A microRNA-129-5p/Rbfox crosstalk coordinates homeostatic downscaling of excitatory synapses. |
| Q38456688 | Analysis of Altered Micro RNA Expression Profiles in Focal Cortical Dysplasia IIB. |
| Q38538748 | Bioactive Functions of Milk Proteins: a Comparative Genomics Approach. |
| Q40079739 | Can we protect the brain via preconditioning? Role of microRNAs in neuroprotection. |
| Q47246759 | Changes in microRNA expression in the brachial plexus avulsion model of neuropathic pain |
| Q34545095 | Changes in microRNA expression in the whole hippocampus and hippocampal synaptoneurosome fraction following pilocarpine induced status epilepticus |
| Q30617784 | Different microRNA profiles in chronic epilepsy versus acute seizure mouse models |
| Q37282427 | Differential expression of miR-184 in temporal lobe epilepsy patients with and without hippocampal sclerosis - Influence on microglial function |
| Q34586669 | Differential temporal expression of milk miRNA during the lactation cycle of the marsupial tammar wallaby (Macropus eugenii) |
| Q93350425 | Down-Regulation of Mir-145 Improves Learning and Memory Abilities in Epileptic Rats by Regulating Hippocampal Neuron Apoptosis |
| Q51072000 | Epigenetics and Epilepsy. |
| Q90201702 | Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents |
| Q48212966 | Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy |
| Q30576606 | Genome-wide microRNA expression profiles in hippocampus of rats with chronic temporal lobe epilepsy |
| Q35036382 | Genome-wide microRNA profiling of rat hippocampus after status epilepticus induced by amygdala stimulation identifies modulators of neuronal apoptosis |
| Q35593533 | Grouping Pentylenetetrazol-Induced Epileptic Rats According to Memory Impairment and MicroRNA Expression Profiles in the Hippocampus |
| Q36151066 | Identification of microRNAs with Dysregulated Expression in Status Epilepticus Induced Epileptogenesis |
| Q38414669 | Inhibition of miR-203 Reduces Spontaneous Recurrent Seizures in Mice |
| Q30818838 | Inhibition of microRNA 128 promotes excitability of cultured cortical neuronal networks |
| Q38840417 | Involvement of microRNAs in epileptogenesis |
| Q64085834 | Long-Term Effects of Myoinositol on Behavioural Seizures and Biochemical Changes Evoked by Kainic Acid Induced Epileptogenesis |
| Q38711083 | MicroRNA Changes in Preconditioning-Induced Neuroprotection |
| Q34023217 | MicroRNA and epilepsy: profiling, functions and potential clinical applications |
| Q38621339 | MicroRNA expression profiles in chronic epilepsy rats and neuroprotection from seizures by targeting miR-344a. |
| Q38151088 | MicroRNA regulation and dysregulation in epilepsy |
| Q47888887 | MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application |
| Q90284161 | MicroRNAs as Potential Biomarkers for Childhood Epilepsy |
| Q96431878 | MicroRNAs as regulators of brain function and targets for treatment of epilepsy |
| Q39006916 | MicroRNAs in epilepsy: pathophysiology and clinical utility |
| Q27004814 | MicroRNAs in the pathophysiology and treatment of status epilepticus |
| Q37529408 | Modulation of miR-146a/complement factor H-mediated inflammatory responses in a rat model of temporal lobe epilepsy |
| Q57493530 | Potential Role of miRNAs as Theranostic Biomarkers of Epilepsy |
| Q38843289 | Proteomic Analysis After Status Epilepticus Identifies UCHL1 as Protective Against Hippocampal Injury |
| Q47550368 | Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis. |
| Q27003832 | Role of MicroRNAs in innate neuroprotection mechanisms due to preconditioning of the brain |
| Q55454949 | Role of non-coding RNAs in non-aging-related neurological disorders. |
| Q35502525 | SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients |
| Q34613797 | Sex, epilepsy, and epigenetics |
| Q48516897 | miR-184 regulates ezrin, LAMP-1 expression, affects phagocytosis in human retinal pigment epithelium and is downregulated in age-related macular degeneration |
| Q55254308 | miRNA-Mediated Regulation of Adult Hippocampal Neurogenesis; Implications for Epilepsy. |
| Q26777282 | miRNAs: biological and clinical determinants in epilepsy |
| Q38668244 | microRNA and Epilepsy |
| Q60958314 | microRNAs Sculpt Neuronal Communication in a Tight Balance That Is Lost in Neurological Disease |
Search more.